Zitrogram

Azithromycin

Zitrogram

Active substance

Azithromycin

Strenght and pharmaceutical forms

500 mg film-coated tablets - 3 tablets

ATC

J01FA10 - Antibacterials for systemic use - Macrolides

Therapeutic Indications

Treatment of infections when caused by germs sensitive to azithromycin.
• upper respiratory tract infections (including otitis media, sinusitis, tonsillitis and pharyngitis);
• lower respiratory tract infections (including bronchitis and pneumonia);
• odontostomatologic infections;
• skin and soft tissue infections;
• non-gonococcal urethritis (caused by Chlamydia trachomatis);
• soft chancre (caused by Haemophilus ducreyi).

Marketing Authorization Holder

Magis Farmaceutici S.r.l.

Dealership for sale

Aesculapius Farmaceutici S.r.l.

Download area

Summary of Product Characteristics – Zitrogram


Products of the same therapeutic areas

Events

06-07/12/2019

XVI CONGR NAZ FLEBOFORUM- XIV SIMPOSIO MALATTIA VARICOSA- VII FLEB WINTER FARM

NAPOLI

XVI CONGR NAZ FLEBOFORUM- XIV SIMPOSIO MALATTIA VARICOSA- VII FLEB WINTER FARM

 Download

08-10/11/2019

XXXII CONGRESSO NAZIONALE SNaMID

CATANIA

XXXII CONGRESSO NAZIONALE SNaMID